Skip to content

Public FDA record

Z-3017-2020: Olympus Medical Systems Corporation (OMSC) Evis Exera II Bronchovideoscope Olympus BF Type Q180 (BF-Q180)

Recall record Z-3017-2020 for Olympus Corporation of the Americas. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-3017-2020
Company in FDA record
Olympus Corporation of the Americas
FDA record creation date
Sep 25, 2020
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

The BF-Q180 bronchoscope is being recalled because it does not have a 510(k) clearance, and the device is associated with a higher rate of patient infections than other comparable OMSC bronchoscopes.

Source facts

Action
Olympus Corporation notified direct customer accounts on 08/31/2020 via recall notification letter. Letter states reason for recall, health risk, and action to take. Actions to be taken by customers include the following: 1. Inspect your inventory and identify any BF-Q180 models. 2. Call your Olympus customer service representative at 1-888-524-7266 option 1 to make arrangements to return your BF-Q180 bronchoscope and discuss replacement options. Olympus will issue a Return Material Authorization for you to return any BF-Q180 at no charge. 3. The timing to return your BF-Q180 and receive a replacement product from Olympus will depend on existing inventory. An Olympus representative will inform you of the approximate timing for your return/replacement. 4. In recognition of the need to continue to serve patients, the BF-Q180 may be continued to be used clinically until suitable alternatives are sufficiently available. Olympus recommends continued adherence to the Instructions for Use related to reprocessing. Customers should note that the BF-Q180 has been validated for High Level Disinfection (HLD), Ethylene Oxide Sterilization and Sterrad NX. Clinical support staff is available to answer questions related to all reprocessing procedures. 5. Olympus will reimburse you $10,000 for each returned BF-Q180. 6. Access the Olympus recall portal to indicate that you have received this notification. Go to https ://olympusamerica.com/recall. Enter the recall number Recall-0366 and provide your contact information as indicated in the portal. 7. If you may have further distributed the BF-Q180, please identify your customers, notify them at once of this product recall, and appropriately document your notification process. Your notification to your customers may be enhanced by including a copy of this recall notification letter.
Initiated
2020-08-31
Root cause
Device Design
Terminated
2024-02-14
Distribution
Worldwide distribution - US Nationwide and International.
Recall number
Z-3017-2020
Recall status
Terminated
CDRH record ID
183562
FDA record created
2020-09-25
Recall event number
86384

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗